Hanmi to construct new plant for Cephalosporin antibiotics.

Published: 2006-03-29 07:00:00

Updated: 2006-03-29 07:00:00

Hanmi announced on March 23 that the board of director determined to construct a global standard of Cephalosporin antibiotic plant in conformance to the EU and cGMP standards at Pyongtaek by 32.4 billion won of investment starting from March 2006 to Dec. 2007.

Hanmi achieved 376,540 million wo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK